Biopharma on a Tear After Certificate of Grant from Japanese Patent Office
26 June 2024 - 2:26AM
AllPennyStocks.com
This biopharma is developing novel cancer treatments for
patients suffering from recurring and metastatic cancer. Shares
were trading up after the firm announced that a Certificate of
Grant for...
To read the full story on AllPennyStocks.com, click
here.
Propanc Biopharma (PK) (USOTC:PPCB)
Historical Stock Chart
From Dec 2024 to Jan 2025
Propanc Biopharma (PK) (USOTC:PPCB)
Historical Stock Chart
From Jan 2024 to Jan 2025